{"id":"https://openalex.org/W4375856447","doi":"https://doi.org/10.1002/cam4.6041","title":"Pegylated liposomal doxorubicin ( PLD ) in daily practice\u2014A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer","display_name":"Pegylated liposomal doxorubicin ( PLD ) in daily practice\u2014A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer","publication_year":2023,"publication_date":"2023-05-06","ids":{"openalex":"https://openalex.org/W4375856447","doi":"https://doi.org/10.1002/cam4.6041","pmid":"https://pubmed.ncbi.nlm.nih.gov/37148541","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10315717"},"language":"en","primary_location":{"id":"doi:10.1002/cam4.6041","doi":"https://doi.org/10.1002/cam4.6041","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.6041","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.6041","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.6041","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077155140","display_name":"Till Wallrabenstein","orcid":"https://orcid.org/0000-0002-6672-3135","observed_orcids":["https://orcid.org/0000-0002-6672-3135"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH","DE"],"is_corresponding":true,"raw_author_name":"T. Wallrabenstein","raw_affiliation_strings":["Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany","Medical Oncology, University Hospital Basel, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-6672-3135","affiliations":[{"raw_affiliation_string":"Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]},{"raw_affiliation_string":"Medical Oncology, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035980393","display_name":"Eveline Daetwyler","orcid":"https://orcid.org/0000-0001-5800-6446","observed_orcids":["https://orcid.org/0000-0001-5800-6446"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"E. Daetwyler","raw_affiliation_strings":["Medical Oncology, University Hospital Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001886951","display_name":"Anton Oseledchyk","orcid":"https://orcid.org/0009-0008-8953-5103","observed_orcids":["https://orcid.org/0009-0008-8953-5103"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"A. Oseledchyk","raw_affiliation_strings":["Medical Oncology, University Hospital Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067045410","display_name":"Christoph F. Rochlitz","orcid":"https://orcid.org/0000-0001-7808-2497","observed_orcids":["https://orcid.org/0000-0001-7808-2497"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"C. Rochlitz","raw_affiliation_strings":["Medical Oncology, University Hospital Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004165533","display_name":"Marcus Hermann Friedrich Vetter","orcid":"https://orcid.org/0009-0004-1003-1078","observed_orcids":["https://orcid.org/0009-0004-1003-1078","https://orcid.org/0000-0002-1785-4876"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]},{"id":"https://openalex.org/I4210091012","display_name":"Kantonsspital Baselland","ror":"https://ror.org/00b747122","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210091012"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M. Vetter","raw_affiliation_strings":["Medical Oncology, Kantonsspital Baselland, Liestal, Switzerland","Medical Oncology, University Hospital Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Kantonsspital Baselland, Liestal, Switzerland","institution_ids":["https://openalex.org/I4210091012"]},{"raw_affiliation_string":"Medical Oncology, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5077155140"],"corresponding_institution_ids":["https://openalex.org/I2801240073","https://openalex.org/I2802542264"],"apc_list":{"value":4070,"currency":"USD","value_usd":4070},"apc_paid":{"value":2932,"currency":"EUR","value_usd":3162},"fwci":0.4684,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.53545869,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"12","issue":"12","first_page":"13388","last_page":"13396"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7226999998092651,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7226999998092651,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.21130000054836273,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylated-liposomal-doxorubicin","display_name":"pegylated liposomal doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":1.0},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9570000171661377},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.9919999837875366},{"id":"https://openalex.org/keywords/single-agent-chemotherapy","display_name":"single-agent chemotherapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8740000128746033},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9359999895095825},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7549999952316284},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9200000166893005},{"id":"https://openalex.org/keywords/age-as-prognostic-factor","display_name":"age as prognostic factor","score":0.8809999823570251},{"id":"https://openalex.org/keywords/efficacy-effectiveness-gap","display_name":"efficacy-effectiveness gap","score":0.8180000185966492},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8333609104156494},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.8219771385192871},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6887311935424805},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6476930975914001},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.6229336261749268},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.6188814043998718},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5894851684570312},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5034326910972595},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.4980051517486572},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49160274863243103},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4915212094783783},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.44782933592796326},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4129208028316498},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.15118929743766785},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.14308428764343262}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/cam4.6041","doi":"https://doi.org/10.1002/cam4.6041","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.6041","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.6041","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10315717","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10315717","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10315717/pdf/CAM4-12-13388.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Med","raw_type":"Text"},{"id":"pmid:37148541","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37148541","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:10883d6fa71a4a53baab3fbb122d8220","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/10883d6fa71a4a53baab3fbb122d8220","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Medicine, Vol 12, Iss 12, Pp 13388-13396 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/cam4.6041","doi":"https://doi.org/10.1002/cam4.6041","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.6041","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.6041","source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4375856447.pdf","grobid_xml":"https://content.openalex.org/works/W4375856447.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W16645327","https://openalex.org/W1804680040","https://openalex.org/W2015815662","https://openalex.org/W2019607817","https://openalex.org/W2025689023","https://openalex.org/W2029806129","https://openalex.org/W2066072138","https://openalex.org/W2071391095","https://openalex.org/W2089726740","https://openalex.org/W2096593771","https://openalex.org/W2136488739","https://openalex.org/W2171015116","https://openalex.org/W2560635244","https://openalex.org/W2728007121","https://openalex.org/W2996630100","https://openalex.org/W3010197652","https://openalex.org/W3012380787","https://openalex.org/W3156985612","https://openalex.org/W4206666777","https://openalex.org/W4319290974"],"related_works":["https://openalex.org/W4307117699","https://openalex.org/W2029806129","https://openalex.org/W2161336169","https://openalex.org/W2596249302","https://openalex.org/W2051169775","https://openalex.org/W2130976864","https://openalex.org/W2015815662","https://openalex.org/W2024301412","https://openalex.org/W2223233270","https://openalex.org/W2153302882"],"abstract_inverted_index":{"PURPOSE:":[0],"Real-world":[1],"data":[2],"about":[3],"pegylated":[4],"liposomal":[5],"doxorubicin":[6],"(PLD)":[7],"in":[8,26,106,155,187,191,225,233],"patients":[9,32,34,46,99,123,234,239],"with":[10,35,37,47,52,100,124,134,235,240],"metastatic":[11],"breast":[12,49],"cancer":[13,50],"(MBC)":[14],"are":[15],"limited.":[16],"We":[17,40,88],"have":[18],"aimed":[19],"to":[20,68,251,261,267],"highlight":[21],"the":[22,56],"role":[23],"of":[24,44,246],"PLD":[25,54,105,135,228,247],"daily":[27],"practice":[28],"focusing":[29],"on":[30],"older":[31,117,226,238],"and":[33,62,83,91,121,130,139,169,205,237],"comorbidities":[36,170,236],"MBC.":[38,241],"METHODS:":[39],"analyzed":[41],"electronic":[42],"records":[43],"all":[45,257],"advanced/metastatic":[48],"treated":[51],"single-agent":[53,104],"at":[55],"University":[57],"Hospital":[58],"Basel":[59],"between":[60],"2003":[61],"2021.":[63],"Primary":[64],"endpoint":[65],"was":[66,144,221],"time":[67],"next":[69],"chemotherapy":[70],"or":[71],"death":[72],"(TTNC).":[73],"Secondary":[74],"endpoints":[75],"were":[76,110,116,136],"overall":[77,84],"survival":[78,81],"(OS),":[79],"progression-free":[80],"(PFS),":[82],"response":[85],"rate":[86],"(ORR).":[87],"performed":[89],"univariate":[90,188],"multivariate":[92,156,192],"analysis":[93,157,193],"for":[94,132,197],"clinical":[95],"variables.":[96],"RESULTS:":[97],"112":[98],"MBC":[101],"having":[102],"received":[103],"any":[107],"treatment":[108,133,231],"line":[109],"analyzed,":[111],"including":[112],"34":[113],"patient":[114],"who":[115],"than":[118],"70":[119],"years":[120,148],"61":[122],"relevant":[125,252],"comorbidities.":[126],"Median":[127],"TTNC,":[128],"OS,":[129],"PFS":[131],"4.6,":[137],"11.9,":[138],"4.4":[140],"months,":[141,183],"respectively.":[142],"ORR":[143],"13.6%.":[145],"Age":[146,168,213],">70":[147],"predicted":[149,179,214],"shorter":[150,215,224],"OS":[151,206,216,220],"(median":[152],"11.2":[153],"months)":[154],"(hazard":[158],"ratio":[159],"[HR]":[160],"1.83,":[161],"95%":[162],"CI":[163],"1.07-3.11,":[164],"p":[165,184,202,209],"=":[166,185,203,210],"0.026).":[167],"did":[171],"not":[172,222],"significantly":[173,217],"affect":[174],"other":[175],"endpoints.":[176],"Unexpectedly,":[177],"hypertension":[178],"longer":[180],"TTNC":[181,199],"(8.3":[182],"0.04)":[186],"analysis,":[189],"maintained":[190],"as":[194],"a":[195,230],"trend":[196],"both":[198],"(HR":[200,207],"0.62,":[201],"0.07)":[204],"0.63,":[208],"0.1).":[211],"CONCLUSION:":[212],"but":[218],"median":[219],"relevantly":[223],"patients.":[227],"remains":[229],"option":[232],"However,":[242],"our":[243],"real-world":[244],"results":[245],"appear":[248],"underwhelming":[249],"compared":[250],"phase":[253],"II":[254],"trials":[255],"through":[256],"age":[258],"groups,":[259],"pointing":[260],"an":[262],"efficacy-effectiveness":[263],"gap,":[264],"possibly":[265],"due":[266],"sampling":[268],"bias.":[269]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-05-10T00:00:00"}